Lighting up three-dimensional nanolantern for circular RNA imaging and precise gene therapy
Zheng Shi,
Jinping Hu,
Zichen Jiao
и другие.
Biosensors and Bioelectronics,
Год журнала:
2025,
Номер
276, С. 117273 - 117273
Опубликована: Фев. 15, 2025
Язык: Английский
A catalytic hairpin assembly-assisted magnetic SERS platform with core-satellite structure for ultra-sensitive circRNA detection in early lung cancer screening
Luyun Xu,
Yongshi Shen,
Zhizhong Lin
и другие.
Chemical Engineering Journal,
Год журнала:
2025,
Номер
unknown, С. 163309 - 163309
Опубликована: Май 1, 2025
Язык: Английский
Novel Approaches in CRISPR/Cas12a-Based Sensing for HCC Diagnosis-A Review (2020-2025)
Journal of Pharmaceutical and Biomedical Analysis,
Год журнала:
2025,
Номер
262, С. 116878 - 116878
Опубликована: Апрель 8, 2025
Язык: Английский
Recent Advances in the CRISPR/Cas-Based Nucleic Acid Biosensor for Food Analysis: A Review
Foods,
Год журнала:
2024,
Номер
13(20), С. 3222 - 3222
Опубликована: Окт. 10, 2024
Food
safety
is
a
major
public
health
issue
of
global
concern.
In
recent
years,
the
CRISPR/Cas
system
has
shown
promise
in
field
molecular
detection.
The
been
coupled
with
various
nucleic
acid
amplification
methods
and
combined
different
signal
output
systems
to
develop
new
generation
CRISPR/Cas-based
biosensor
technology.
This
review
describes
design
concept
its
application
food
analysis.
A
detailed
overview
systems,
methods,
strategies
provided.
biosensors
have
advantages
high
sensitivity,
strong
specificity,
timeliness,
achieving
fast
analysis
variety
targets,
including
bacteria,
toxins,
metal
ions,
pesticides,
veterinary
drugs,
adulteration,
promoting
development
rapid
detection
At
end,
we
also
provide
our
outlook
for
future
biosensors.
Язык: Английский
Quantitative Analysis of Cell-Free RNA at Attomolar Level Using CRISPR/Cas Digital Imaging Platform
Y Li,
Fenglei Quan,
Yige Wu
и другие.
Analytical Chemistry,
Год журнала:
2024,
Номер
96(43), С. 17362 - 17369
Опубликована: Окт. 16, 2024
Quantitative
analysis
of
cell-free
RNA
(cfRNA)
in
plasma
sample
can
be
used
for
screening,
diagnosing,
and
prognosticating
multiple
diseases.
Here,
we
report
a
quantitative
CRISPR/Cas
digital
imaging
platform
(qCasdip)
the
detection
various
cfRNAs,
including
circular
RNAs
miRNAs,
clinical
samples
at
attomolar
(aM)
level
without
need
preamplification.
Digital
counting
strategy
provides
qCasdip
ability
with
linear
range
10
Язык: Английский